Dating ViolenceETHR2NCT07039253
Pilot Trial of Clinic-based Dating Violence Prevention Program for Adolescents and Caregivers
A study testing Engaging Together for Health Relationships in people with Dating Violence and Parent, run by University of Pittsburgh at 1 site in United States.
Trial summary
ETHR V 2.0 pilot trial is a one-arm, multi-site pilot trial to assess the acceptability and feasibility of Engaging Together for Healthy Relationships, a caregiver-adolescent dating violence prevention program delivered within pediatric primary care. Read more about this study
- Who is it for?
- Ages 12 years and olderHealthy volunteers can take part
- Conditions the study is for
- Dating Violence, Parent, Primary Care
- What is being tested?
- Engaging Together for Health Relationships
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 120 participants
- Where
- 1 siteUnited States
- Study dates
- 15 Aug 2025to 15 Jun 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 years and older
- All sexes
- Healthy volunteers accepted
- Child, Adult, Older adult
Who may be able to join
- Providers:
- Sees patient at an eligible primary care clinic
- Speaks and understands English
- Age 18 or older
- Identifies as a pediatrician, nurse practitioner, physician assistant (pediatric primary care healthcare provider)
- Adolescents
Show all 16Show fewer
- Age 12 to 16
- Attending an upcoming well-child visit from a provider enrolled in the study
- Caregiver who is accompanying well-child visit with adolescent is also participating
- Speaks and understands English
- Parents
- Is parent or primary caregiver for an adolescent age 12 to 16
- Adolescent has an upcoming well-child visit with a provider enrolled in the study
- Accompanying child to the well-visit
- Adolescent is interested and eligible to participate in study
- Speaks and understand English
Who cannot join
- Unable to assent/consent
- Does not meet inclusion criteria
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
UPMC Children's Community Practice
Monongahela, Pennsylvania, 15063
Patrick Tate, MD, +1 412-882-7747, patrick.tate2@chp.edu
Erin Mickievicz, BA, 4126926000, mickieviczee@upmc.edu
About this study
Official title: Engaging Together for Healthy Relationships Version 2.0: Multisite Pilot Intervention Trial
ETHR V 2.0 pilot trial is a one-arm, multi-site pilot trial to assess the acceptability and feasibility of Engaging Together for Healthy Relationships, a caregiver-adolescent dating violence prevention program delivered within pediatric primary care.
Read the detailed description
ETHR V 2.0 pilot trial is a one-arm (intervention only) pilot trial of Engaging Together for Healthy Relationships, a caregiver-adolescent dating violence prevention program delivered within pediatric primary care. We completed one round of the pilot trial in two clinics in Pittsburgh and now are expanding the trial to include two sites with all providers in each site. ETHR includes clinician training, in-clinic resources, and after visit text messages and resources for families. This is an intervention only trial to assess acceptability, feasibility, and exploratory pre/post changes in outcomes.
- Conditions
- Dating Violence, Parent, Primary Care
- Being tested
- Engaging Together for Health Relationships
- Keywords
- dating violence prevention, parental monitoring and communication, pilot trial, middle school
- Medical subject headings
- Communication
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Engaging Together for Health RelationshipsBehavioural
Dating violence intervention for caregivers and adolescents to be delivered within pediatric primary care
| Study group | Role | What they receive |
|---|---|---|
| Engaging Together for Healthy Relationships | Experimental | Providers and families in the intervention arm will receive the ETHR program which includes a clinician training, provider scripts, resource guides, a take home box for families, post-visit text messages, a comprehensive website, and warm referral processes. Receives: Behavioral: Engaging Together for Health Relationships |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of participants who are eligible out of the total who are approached
Will assess through tracking data
Measured: Through completion of study recruitment, an average of 6 months
Percentage of participants who are consented out of the total who are eligible
Will assess through tracking data
Measured: Through completion of study recruitment, an average of 6 months
Percentage of participants who complete the baseline survey out of the total who consented
Will assess through tracking data
Measured: Through completion of completing baseline surveys, an average of 6 months
Percentage of participants who complete the well-visit out of the total who consented
Will assess through tracking data
Measured: Through completion of completing well-visits, an average of 6 months
Percentage of participants who complete the immediate post-intervention survey out of the total who consented
Will assess through tracking data
Measured: Through completion of completing post-intervention survey, an average of 7 months
Percentage of participants who complete the 1-month post-intervention survey out of the total who consented
Through completion of completing 1- month post-intervention survey, an average of 8 months
Measured: 4 months
Percentage of participants who complete the 3-month post-intervention survey out of the total who consented
Will assess through tracking data
Measured: Through completion of completing 3 month post-intervention survey, an average of 12 months
Percentage of participants who strongly agree or agree that the intervention is acceptable using a 4-item validated measure (Acceptability of Intervention Measure)
Validated measure (Acceptability of Intervention Measure)
Measured: Through completion of completing immediate post-visit surveys, an average of 6 months
Percent of participants who received intervention during pediatric primary care visit
Investigator-developed measure with questions about what components of the intervention were received during the well visit
Measured: Through completion of completing well-visits, an average of 6 months
Participants use intervention resources after the visit
Investigator-developed measure on use of intervention resources after the visit
Measured: Through completion of intervention, on average 3 months post well visit
Secondary outcomes (8)
Self-efficacy in preventing adolescent relationship abuse (ARA), change in outcome between baseline and 3 months
Self-efficacy around ARA prevention, 1-5 scale (5=higher self-efficacy)
Measured: Baseline, 3-month post intervention
Percentage of participants who utilize ARA resources at each measurement point, change in outcome over time
Investigator developed measure (yes/no)
Measured: Baseline, 1 month post intervention, 3 month post-intervention
Attitudes about ARA, change in outcome between baseline and 3 months
Attitudes about Abusive Relationships, 1-5 scale (1=not abusive, 5=very abusive)
Measured: Baseline, 3-month post intervention
Motivation around preventing dating violence
Investigator developed measure, 1-5 scale (1=not motivated, 5=very motivated)
Measured: Baseline, 3-month post intervention
Parent-adolescent communication around dating and ARA, change in outcome over time
Investigator developed measure, yes/no answer choices (yes=has communicated, no=has not communicated)
Measured: Baseline, 3-month post intervention
Parental monitoring around dating and ARA, change in outcome over time
Investigator developed measure, 1-5 scale (1=never; 5=always)
Measured: Baseline, 3-month post intervention
Percentage of adolescents reporting ARA victimization and perpetration
CADRI Short Form 1-5 scale (never to everyday)
Measured: Baseline, 3-month post intervention
ARA knowledge
3 questions assessing ARA knowledge (yes/no answer choices)
Measured: baseline, 3 months surveys (6 months total)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jun 2025
- Study start15 Aug 2025
- Primary completion1 Jan 2027 (estimated)
- Study completion15 Jun 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Dating ViolenceStudies of the same condition, open and under way.
- More trials run by University of PittsburghThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 120 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Pittsburgh
- Sponsor type
- University, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Responsible party
- Principal investigator, Maya Ragavan, University of Pittsburgh
- Investigators
- Maya Ragavan, MD, MPH, MS, Principal investigator, University of Pittsburgh
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07039253
- Sponsor's protocol ID
- STUDY25030017
- Other IDs
- 1R21HD109627-01A1
- Acronym
- ETHR2
- Status last verified
- Jun 2026
- First submitted
- 18 Jun 2025
- Last updated
- 4 Jun 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: To protect confidentiality and due to the sensitivity of this topic, we will not share IDP
Study at a glance
From the registry record, last updated by the sponsor on 4 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Engaging Together for Healthy Relationships Version 2.0: Multisite Pilot Intervention Trial
- ClinicalTrials.gov ID
- NCT07039253
- Acronym / sponsor ID
- ETHR2 / STUDY25030017
- Conditions
- Dating Violence, Parent, Primary Care
- Keywords
- dating violence prevention, parental monitoring and communication, pilot trial, middle school
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 120 participants (estimated)
- Lead sponsor
- University of PittsburghUniversity, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Study start
- 15 Aug 2025 (actual)
- Primary completion
- 1 Jan 2027 (estimated)
- Study completion
- 15 Jun 2027 (estimated)
- First posted
- 26 Jun 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
ETHR V 2.0 pilot trial is a one-arm, multi-site pilot trial to assess the acceptability and feasibility of Engaging Together for Healthy Relationships, a caregiver-adolescent dating violence prevention program delivered within pediatric primary care.
Detailed description
ETHR V 2.0 pilot trial is a one-arm (intervention only) pilot trial of Engaging Together for Healthy Relationships, a caregiver-adolescent dating violence prevention program delivered within pediatric primary care. We completed one round of the pilot trial in two clinics in Pittsburgh and now are expanding the trial to include two sites with all providers in each site. ETHR includes clinician training, in-clinic resources, and after visit text messages and resources for families. This is an intervention only trial to assess acceptability, feasibility, and exploratory pre/post changes in outcomes.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Engaging Together for Healthy Relationships | Experimental | Behavioral: Engaging Together for Health RelationshipsProviders and families in the intervention arm will receive the ETHR program which includes a clinician training, provider scripts, resource guides, a take home box for families, post-visit text messages, a comprehensive website, and warm referral processes. |
Who may qualify
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (16 listed)
- Sees patient at an eligible primary care clinic
- Speaks and understands English
- Age 18 or older
- Identifies as a pediatrician, nurse practitioner, physician assistant (pediatric primary care healthcare provider)
- Adolescents
Key exclusion criteria (2 listed)
- Unable to assent/consent
- Does not meet inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Engaging Together for Health RelationshipsDating violence intervention for caregivers and adolescents to be delivered within pediatric primary care | Behavioural | Engaging Together for Healthy Relationships |
Primary outcome
Percentage of participants who are eligible out of the total who are approached
Time frame: Through completion of study recruitment, an average of 6 months
Will assess through tracking data
Percentage of participants who are consented out of the total who are eligible
Time frame: Through completion of study recruitment, an average of 6 months
Will assess through tracking data
Percentage of participants who complete the baseline survey out of the total who consented
Time frame: Through completion of completing baseline surveys, an average of 6 months
Will assess through tracking data
Percentage of participants who complete the well-visit out of the total who consented
Time frame: Through completion of completing well-visits, an average of 6 months
Will assess through tracking data
Percentage of participants who complete the immediate post-intervention survey out of the total who consented
Time frame: Through completion of completing post-intervention survey, an average of 7 months
Will assess through tracking data
Percentage of participants who complete the 1-month post-intervention survey out of the total who consented
Time frame: 4 months
Through completion of completing 1- month post-intervention survey, an average of 8 months
Percentage of participants who complete the 3-month post-intervention survey out of the total who consented
Time frame: Through completion of completing 3 month post-intervention survey, an average of 12 months
Will assess through tracking data
Percentage of participants who strongly agree or agree that the intervention is acceptable using a 4-item validated measure (Acceptability of Intervention Measure)
Time frame: Through completion of completing immediate post-visit surveys, an average of 6 months
Validated measure (Acceptability of Intervention Measure)
Percent of participants who received intervention during pediatric primary care visit
Time frame: Through completion of completing well-visits, an average of 6 months
Investigator-developed measure with questions about what components of the intervention were received during the well visit
Participants use intervention resources after the visit
Time frame: Through completion of intervention, on average 3 months post well visit
Investigator-developed measure on use of intervention resources after the visit
8 secondary outcomes
Self-efficacy in preventing adolescent relationship abuse (ARA), change in outcome between baseline and 3 months
Time frame: Baseline, 3-month post intervention
Percentage of participants who utilize ARA resources at each measurement point, change in outcome over time
Time frame: Baseline, 1 month post intervention, 3 month post-intervention
Attitudes about ARA, change in outcome between baseline and 3 months
Time frame: Baseline, 3-month post intervention
Motivation around preventing dating violence
Time frame: Baseline, 3-month post intervention
Parent-adolescent communication around dating and ARA, change in outcome over time
Time frame: Baseline, 3-month post intervention
Parental monitoring around dating and ARA, change in outcome over time
Time frame: Baseline, 3-month post intervention
Percentage of adolescents reporting ARA victimization and perpetration
Time frame: Baseline, 3-month post intervention
ARA knowledge
Time frame: baseline, 3 months surveys (6 months total)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Jun 2026.
- Individual participant dataSharing planned: No. To protect confidentiality and due to the sensitivity of this topic, we will not share IDP
Related trials for Dating Violence
Not yet recruiting
Comparison of Escape Room and Branching Scenario Games in Nursing Education
Gender Prediction, Dating Violence
Not yet recruiting
Lakota Family Acceptance Project Pilot RCT
LGBTQ, Racial Disparities
Recruiting
Caregiver-Adolescent Dating Violence Prevention Intervention Pilot Trial
Adolescent Relationship Abuse, Sexual and Gender Minorities
Not yet recruitingObservational study
Evaluation of State-Level Sexual and Gender Minority Laws for the Primary Prevention of Sexual and Intimate Partner Violence Among Sexual and Gender Minority Youth in the U.S.
Sexual Violence, Intimate Partner Violence (IPV)
Active, not recruitingObservational study
Longitudinal Investigation of the Risk and Protective Factors of Dating Violence (Dating it Safe) - Firearms
Dating Violence, Firearm Injury and Violence
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Maya Ragavan, MD, MPH, MS principal investigator
University of Pittsburgh
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Engaging Together for Health Relationships in people with Dating Violence and Parent, run by University of Pittsburgh at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 16 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 4 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Erin Mickievicz, BA (14126926000, mickieviczee@upmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of participants who are eligible out of the total who are approached (time frame: Through completion of study recruitment, an average of 6 months). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Jun 2026.